Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB0003340550 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.25 1,231,802 08:00:00
Bid Price Offer Price High Price Low Price Open Price
1.20 1.30 1.25 1.25 1.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 0.45 -1.41 -0.22 13
Last Trade Time Trade Type Trade Size Trade Price Currency
15:49:34 O 270 1.201 GBX

Feedback (FDBK) Latest News

More Feedback News
Feedback Investors    Feedback Takeover Rumours

Feedback (FDBK) Discussions and Chat

Feedback Forums and Chat

Date Time Title Posts
09/4/202119:23FEEDBACK plc Medical Imaging Technology7,673
04/11/201907:39Feedback 35
01/11/201815:33****Feedback PLC****3,006
03/2/201011:50Feedback looks interesting - could easily be a ten bagger over next year396
03/9/200211:53ainsley long .........................quick shart it2

Add a New Thread

Feedback (FDBK) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Feedback trades in real-time

Feedback (FDBK) Top Chat Posts

DateSubject
11/4/2021
09:20
Feedback Daily Update: Feedback Plc is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 1.25p.
Feedback Plc has a 4 week average price of 1.23p and a 12 week average price of 1.08p.
The 1 year high share price is 2.40p while the 1 year low share price is currently 0.58p.
There are currently 1,066,931,686 shares in issue and the average daily traded volume is 2,592,188 shares. The market capitalisation of Feedback Plc is £13,336,646.08.
26/3/2021
17:44
lr2: Always fun when they hide the buys. FYI - Share Prophets ran a small item on Feedback yesterday. Here's a look at it for those who don't have access there. ______________________________________ Hello Share Shepherds. A small medical pioneer I’ve commended to your further study before is Feedback (FDBK). It has some clever software to help hospital doctors do their job better. However, the share hasn’t exactly taken off, yet. Never mind, now comes some news which might kick start a better performance. For the first time, the company’s doctor communication system Bleepa has been awarded a direct commercial contract. The Royal Berkshire NHS Foundation Trust is the client and the sum involved is £84,000 for a year’s service. Not a big sum, you’ll say, but the first step towards a profit is often the most important. Actually, the client is the NHS’s Clinical Communications Network. So if this contract in Berkshire succeeds, and is renewed then we can probably expect more hospitals to adopt the system. Once again the virus has benefitted a company because Feedback’s services include the provision of virtual medical meetings. The Bleepa system of this £13 million market cap AIM-listed company also includes doctor referrals to hospital consultants and photo capture of medical photographs in much finer detail than usual. Vital, of course, for diagnosis and treatment. The Royal Berkshire NHS Trust has a happy record of medical innovation and is well positioned to make the Bleepa system work for it. At present some medics use social media platforms to communicate and that’s probably not as ideal as it should be. The pandemic has made the time of hospital consultants even more valuable as they battle with a backlog of cases. Feedback says its way of speeding this up will be very valuable to hospitals, saving both time and money. Can anyone see the NHS of the future not being attracted to benefits like that?
22/3/2021
19:05
lr2: What if they are storing up all the good news for one almighty splash. The share price should rocket and any future placing will hopefully be at a much higher price. Not so good for your patient, risk reduced approach. We kind of know that they have signed up Royal Berkshire Hospital Trust as a job advert leaked out the info. What we don't know is how many more trusts haven't leaked out any info. Is the NHSx money being nibbled away now that the Covid-19 virus pandemic has subsided somewhat? Beginning to think that my belief in April being the pivotal month was a pretty good guess.
27/2/2021
12:42
petekand: Maybe something to do with the alleged p&d chap. #7451 Large player added 3million shares He is not here for peanuts Lets see how it goes Recon share price zooms into 2's today tomorrow
24/2/2021
10:36
alexios1201: Large player added 3million sharesHe is not here for peanutsLets see how it goesRecon share price zooms into 2's today tomorrow
03/2/2021
15:47
sonie01: £12m per year would equate to an increase in share price of 24p as SAAS businesses are given a PE ratio of 20
29/1/2021
20:36
lr2: It was a puzzling visit from Trevor this morning. He previously appeared here on 10th Sept 2019 when the share price was exactly the same price as it is today. Something he remarked upon in his post. Coincidence? Some people say there's no such thing.
29/1/2021
11:42
ydderf: Familiar names are still here though it is now some years later - even the share price is the same though there are many millions more shares now. I guess that's progress as least? You're a loyal bunch, I hope young Tom appreciates it
17/11/2020
18:56
yump: As we are in lockdown, I've been given some DIY to do, so literally will be watching paint dry, rather than the FDBK share price. Just as well really.
06/11/2020
09:13
lr2: And here's the rest. The share price was up 15% as I speak on an jolly statement from the company’s big cheese. He claims that the company has had a ‘transformative year’ during which it developed its main product. This is known as ‘Bleepa’ which Feedback describes as ‘the revolutionary medical imaging communications app’. Bleepa allows doctors to view patients’ conditions in close up at high resolution from their phones or whatever other devices they choose. Feedback started the current year by raising just over £5 million which it needed to expand. And it’s likely to do that because Bleepa is the only such medical imaging system on the NHS’s computer network with a coveted CE marked as a ‘Class I medical device.’ I think that shows deep respect in the hospital world. Also, Feedback has entered a new partnership with an outfit called Axial3D, allowing medics to view and manipulate 3D pictures on their computers. There’s little doubt that more clinicians are becoming more reliant on the Feedback computer images as time goes on. To try to speed up the process, the firm has strengthened its marketing team. Its cash position is perky at £4.4 million, so that gives the share a measure of security. Meanwhile, demands on medical services continue to grow and Feedback offers a system that should make things a lot easier for those at the start-end. The company’s record of making money is poor, which has depressed the share price, but that might soon change. Unlike the Punter’s Return. Never miss a story.
04/11/2020
23:27
lr2: Christmas shopping for the grandkids before lock down then Derby vs QPR (0-1) so a bit late replying to your IQAI post Duc. I see IQAI ended up 183% on an RNS that basically says IQAI have a non-exclusive agreement with the owners of the LSN software, AI metrics, to manufacture, market, and distribute the LSN software platform now the FDA have granted market clearance in the USA. Not sure how IQAI plan to benefit much from this. I don't believe they have any manufacturing presence in the USA, nor any marketing and distribution personnel there either. Could this latest RNS just be another of Trevor Brown's ways of pumping up the IQAI share price prior to another placing? Let's see what tomorrow brings price wise for IQAI? I wouldn't be surprised to see an almighty fall because I sure as hell can't see today's RNS adding much value to IQAI's bottom line unless I've totally missed something of value. Edit - a quick search of the Net tells me that LSN is going to be an independent plugin to OsiriX DICOM viewer that users will pay for independently of the monthly costs of the core OsiriX platform. There's even been a draft user manual available for the last 6 months. So the information about LSN has been out there for awhile. Https://imgbio.atlassian.net/wiki/spaces/UMLSN0101/pages/695271473/LSN+User+Manual+OsiriX+-+en If this is worth a 183% rise in IQAI share price I will be amazed.
Feedback share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
FDBK
Feedback
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210412 02:27:43